ZZZh. Zhalgasbaev

Zh. Zhalgasbaev

*This is an algorithmically generated author record based on publicly available information.

Zh. Zhalgasbaev has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hepatic Failure in Pancreonecrosis and the Development of Abdominal Sepsis

    by S. Kozhakhmetov, K. Rustemova, O. Tsoi, Zh. Ashimov, K. Aknazarov, Zh. Zhalgasbaev, K. Osmonaliev

    It is well known that acute destructive pancreatitis, pancreonecrosis is accompanied by severe endogenous intoxication, often leading to the development of multiple organ failure syndrome, liver failure is one of the important links in this process. The mortality rate of patients with pancreonecrosis related to liver failure is as high as 83%, and approximately 5% of patients with pancreonecrosis have fulminant liver failure. Proven: liver function is closely related to the progression of purulent-necrotic complications in patients with acute destructive pancreonecrosis. The authors present the data of literature on the importance of liver failure in the course and prognosis of acute destructive pancreatitis. The pathogenetic role of lipid peroxidation processes are especially emphasized. The controversial issues of portal and systemic bacteremia and toxemia in the development of pancreatogenic abdominal sepsis are discussed, as well as the involvement of the lymphatic system. The authors’ research aims to analytically dissect and summarize the processes underlying the clinical manifestations of liver failure in pancreatic necrosis and their underlying mechanisms, which may provide new insights for further understanding and better management of liver failure in patients with pancreatic necrosis and abdominal sepsis.

  • Experience of Surgical Treatment of Patients with Acute Necrotizing Pancreatitis

    by K. Sydygaliev, B. Imanov, D. Syrgaev, K. Aknazarov, Zh. Zhalgasbaev, K. Osmonaliev, S. Aknazarov

    Acute pancreatitis occurs as a result of autolysis of pancreatic tissue by lipolytic and activated proteolytic enzymes, which leads to a wide range of changes from edema to focal and extensive necrosis and ranks third in the development of the surgical structure of the abdominal cavity. Destructive forms occur in 30-60% of cases, and mortality fluctuates between 30-85%. The frequency of purulent results reaches 21%. The article presents a technique for the surgical treatment of patients with acute necrotizing pancreatitis.

  • Ulinastatitis in Complex Treatment of Acute Pancreatitis (Literature Review)

    by O. Tsoi, K. Mamakeev, S. Kozhakhmetov, K. Rustemova, Zh. Telmanova, Zh. Zhalgasbaev

    The purpose of this literature review is to assess the completeness and significance of recent research on the treatment of a destructive form of pancreatitis for public health and scientific achievements, highlighting areas that require further detailed study. A review of foreign literature on the use of the protease inhibitor ulinastatin in the complex conservative treatment and prevention of acute pancreatitis is made. The clinical and laboratory effectiveness of the drug in preventing the transition of uninfected pancreatic necrosis into a complicated purulent-necrotic form with the development of abdominal sepsis, as well as the effect on treatment results and mortality, has been demonstrated. Existing schemes and modes of application are given. In recent years, significant scientific achievements have been presented in the field of treatment of acute pancreatitis, especially in the context of its destructive forms. The results of numerous studies have made it possible to formulate recommendations aimed at optimizing treatment approaches and improving the prognosis of this condition. Studies have identified key factors affecting the prognosis and outcome of treatment of acute pancreatitis, including the degree of destruction of the pancreas, clinical and laboratory characteristics of patients, as well as complications associated with various treatment methods. These data will allow surgeons to develop individual treatment strategies, taking into account the specifics of each case. Ulinastatin is not only a protease inhibitor, but also has anti-inflammatory and immunomodulatory properties. Based on the results of numerous foreign studies, the high clinical and laboratory effectiveness of ulinastainin the complex drug therapy of acute pancreatitis has been proven. And also, to prevent it and/or hyperfermentemia during ERCP and extended operations on the organs of the pancreato-duodenal zone. Ulinastatin is most effective in the edematous form of AP and aseptic pancreatic necrosis. In case of infected pacreonecrosis with severe organ-systemic failure or the formation of purulent-necrotic foci in the retroperitoneum (abdominal sepsis), the drug is not effective.

  • GUIDED PROGRAMMED DRUG TREATMENT OF ACUTE DESTRUCTIVE PANCREATITIS

    by Ж.а. Доскалиев, К.р. Рустемова, С.к. Кожахметов, Ж.г. Жалгасбаев, А.а. Гадылбеков, С.т. Оразбаев

    Актуальность. Острый деструктивный панкреатит – это состояние, в ходе которого происходит сложный механизм развития, включающий несколько этапов. Осложнения, возникающие в результате воспаления в поджелудочной железе, могут включать в себя панкреатическую некротизирующую инфекцию, перитонит, абсцессы и системные воспалительные ответы, что может привести к множественной органной недостаточности и даже смерти. Понимание этого механизма развития подчеркивает важность своевременной диагностики и эффективного лечения, чтобы предотвратить тяжелые осложнения и улучшить прогноз для пациентов. Цель исследования. Основной целью было выяснить, может ли комбинация лекарственных веществ улучшить исходы при остром деструктивном панкреатите. Материалы и методы исследования. Разработана программа введения лекарственных веществ непосредственно в орган мишень, путем катетеризации селезеночной артерии. Проанализированы результаты лечения 144 пациентов с острым деструктивным панкреатитом, поступивших в 2020-2023 гг. в хирургическое отделение Городской многопрофильной больницы № 2 города Астана. Возраст больных от 30 до 63 лет. Было преобладание возрастной группы трудоспособного периода с 41 до 63 лет (81,9%). Мужчин было 86 (59,7%), женщин – 58 (40,3%). Результаты исследования. Отсутствие септических осложнений было отмечено у 42 из 72 пациентов в основной группе и у 36 из 72 пациентов в контрольной группе. Срочное хирургическое вмешательство потребовалось у 7 из 72 пациентов в основной группе и у 24 из 72 пациентов в контрольной группе. Уровень смертности составил 4 из 72 в основной группе и 8 из 72 в контрольной группе. Средняя продолжительность пребывания в стационаре была короче у пациентов основной группы. Вывод: исследование показало, что комбинация препаратов, выбранная нами более эффективна в профилактике септических осложнений и снижении смертности при ОДП, чем внутривенная терапия. Background. Acute destructive pancreatitis is a condition in which a complex mechanism of development occurs, including several stages. Complications resulting from inflammation in the pancreas can include pancreatic necrotizing infection, peritonitis, abscesses, and systemic inflammatory responses, which can lead to multiple organ failure and even death. Understanding this developmental mechanism highlights the importance of timely diagnosis and effective treatment to prevent severe complications and improve the prognosis for patients. Purpose of the study. The main goal was to find out whether a combination of drugs can improve outcomes in acute destructive pancreatitis. Materials and research methods: a program for the administration of drugs directly into the target organ by catheterization of the splenic artery has been developed. The results of the treatment of 144 patients with acute destructive pancreatitis who were admitted to the surgical department of the Astana City Multidisciplinary Hospital No. 2 in 2020-2023 were analyzed. The age of the patients is from 30 to 63 years. There was a predominance of the age group of the working age period from 41 to 63 years - (81.9%). There were 86 men (59.7%) and 58 women (40.3%). Study results. The absence of septic complications was noted in 42 out of 72 patients in the main group and in 36 out of 72 patients in the control group. Urgent surgical intervention was required in 7 out of 72 patients in the main group and in 24 out of 72 patients in the control group. The mortality rate was 4 out of 72 in the main group and 8 out of 72 in the control group. The average length of hospital stay was shorter in patients of the main group. Conclusion: the study showed that the combination of drugs chosen by us is more effective in preventing septic complications and reducing mortality in ADP than intravenous therapy.

  • COMPLEX TREATMENT OF ACUTE DESTRUCTIVE PANCREATITIS (LITERATURE REVIEW)

    by К.р. Рустемова, Ж.г. Жалгасбаев, С.к. Кожахметов, А.а. Гадылбеков

    Острый деструктивный панкреатит – грозное хирургическое заболевание, представляющее серьезную проблему из-за своей географической распространенности, тяжелая форма которого связана с высокой заболеваемостью и смертностью. При этом летальность в зависимости от объема воспалительного процесса поджелудочной железы и тяжести течения самой патологии сохраняется на уровне 20% и выше. Целью исследования было изучение и обобщение литературных данных опыта исследователей за последние 10 лет, посвященных поиску наиболее эффективных методов хирургического лечения в комплексе с медикаментозной терапией острого деструктивного панкреатита. Для поиска информации были использованы следующие базы данных: Pubmed, MEDLINE, Embase, Springer, ScienceDirect, Cochraine Library, а также публикации из журналов стран СНГ и РК. После комплексной и стандартизированной оценки учитывались только исследования в которых был представлен опыт комплексного лечения острого деструктивного панкреатита, включавшего непрерывное регионарное артериальное введение лекарственных средств. Acute destructive pancreatitis is a formidable surgical disease that poses a serious problem due to its geographical distribution; the severe form of which is associated with high morbidity and mortality. At the same time, mortality, depending on the volume of the inflammatory process of the pancreas and the severity of the pathology itself, remains at a level of 20% and above. The purpose of the study was to summarize the literature data on the experience of researchers over the past 10 years devoted to the search for the most effective methods of surgical treatment in combination with drug therapy for acute destructive pancreatitis. Pub med, Medline, publications from journals of the CIS countries and the Republic of Kazakhstan were used. After a comprehensive and standardized assessment, only studies that presented experience in complex treatment of acute destructive pancreatitis, including continuous regional arterial administration of drugs, were taken into account.


  • MODERN PRINCIPLES OF TREATMENT OF ACUTE DESTRUCTIVE PANCREATITIS

    by Saken Kozhakhmetov, Kulsara Rustemova, Nurbek Igisinov, Olzhas Akyshev, Abzal Ismatov, Inkar Sagatov, Batyr Aitmoldin, Zhomart Zhalgasbaev, Almaty National Scientific Center Of Surgery N.A. Syzganov A.N.” Jsc, Nur-Sultan Nur-Sultan Mch №2

    Objective. To improve the results of endovideosurgical treatment of patients with acute destructive pancreatitis. Material and methods. The research was carried out at the bases of the Nur-Sultan Multifunctional City Hospital №2 and the Nur-Sultan Multifunctional City Hospital №1. Statistical analysis of the results was carried out using the methods of variation statistics with the calculation of M ± SD. Differences between comparison groups were analyzed using the Wilcoxon-Man-Whitney test and were considered statistically significant at p≤ 0.05. From 2017-2021, 64 patients with acute destructive pancreatitis were treated according to the developed and implemented treatment algorithm: Of these: AP without organ failure and local or systemic complications -10 people. AP of moderate and severe form -54 people. Lethal outcomes-1; The average length of stay in the hospital is 20.8±1.2 days; The mean age was 43 ± 1.3 years. The control group - treatment of patients with moderate and severe acute biliary pancreatitis without the use of ulinostatin (hereinafter US) was n = 122; Lethal outcomes-8. An algorithm for the use of US was developed and implemented depending on the severity of the course of destructive pancreatitis in the complex treatment of patients with AP. Results. 10 patients were treated conservatively. 54 - surgical treatment was combined with the appointment of US according to the developed scheme. Endoscopic surgery was performed in 51 patients; 3 patients were operated on by laparotomy. The average duration of hospital stay in the main group was 3.5±0.34 days less than in the control group. Conclusion. The research results showed the high efficiency of the developed algorithm for endovideosurgical treatment of AP in combination with the use of the US. Received AC №14704 dated January 27, 2021 (www.kazpatent.kz).